UK Pharmaceutical Market Analysis

UK Pharmaceutical Market Analysis


$ 3999

This report presents a strategic analysis of the UK Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UK Pharmaceutical Market, offering unmatched value, accuracy and expert insights.

ID: IN10GBPH020 CATEGORY: Pharmaceuticals GEOGRAPHY: UK

Buy Now

UK Pharmaceutical Market Executive Summary

In 2020, total healthcare spending in the United Kingdom was £257.6 billion, or £3,840 per person. In nominal terms, healthcare spending increased by 15.7 percent in 2020, or 10.0 percent in real terms after inflation; this was the greatest growth rate since the series began in 1997.

In 2020, The total current healthcare expenditure in the United Kingdom was 12.0% of the GDP, up from 9.9% in 2019. Preventive care spending reached £15.7 billion in 2020, up 40.8 percent in real terms, owing partly to increased government spending during the coronavirus (COVID-19) pandemic. The market size, measured by revenue, of the Pharmaceutical Wholesaling industry, is £64.9bn in 2022.

The pharmaceutical industry covers all aspects of medication research, development, production, and distribution. Pharma revenues worldwide reached $1.42 trillion in 2021 due to the market's rapid growth over the previous two decades. With the introduction of new technology as well as more economical and effective manufacturing techniques, the industry has experienced a significant transition. Additionally, the market growth has been positively driven by rising investment flow in this sector.

Market Size and Key Findings

The pharmaceutical market in Europe was estimated to be worth USD 282.75 billion in 2020, and it is anticipated to increase at a CAGR of 5.4% from 2021 to 2028.

UK Pharmaceutical Market Size (In USD Bn) (2021-2030F)

Market Dynamics

Market Growth Drivers Analysis

A rise in drug approvals by regulatory bodies is expected to fuel drug manufacturing procedures. The growth in the approvals of pediatric medicine boosts the growth.

Competitive Landscape

Key Players

Major players in Pharmaceutical Market are F. Hoffmann-La Roche Ltd.; Novartis AG; GlaxoSmithKline plc; Pfizer, Inc.; Merck & Co., Inc.; AstraZeneca; Johnson & Johnson; Sanofi SA; Eli Lilly and Company; AbbVie, Inc.; Sun Pharmaceutical Industries Ltd.; Novo Nordisk A/S; Takeda Pharmaceuticals, Inc.; Cipla Limited; Bristol Myers Squibb Company; Gilead Sciences, Inc.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Pharmaceutical Market Segmentation

Molecule Type (Revenue, USD Billion):

In the pharmaceutical market, small molecule drugs account for the major part of the total UK drug sales.

  • Biologics & Biosimilars (Large Molecules)
  • Conventional Drugs (Small Molecules)

Drug Development Type (Revenue, USD Billion):

Several benefits associated with outsourcing operations are expected to drive the segment growth at a lucrative pace over the coming years. Outsourced services minimize investments, reduce drug development & overall costs, increase the efficiency of manufacturing procedures, and easily comply with different regulatory norms.

  • In-house
  • Outsource

Formulation (Revenue, USD Billion):

  • Tablets
  • Capsules
  • Injectable
  • Sprays
  • Suspensions
  • Powders
  • Other Formulations

Route of administration (Revenue, USD Billion):

  • Oral
  • Topical
  • Parenteral
  • Inhalations
  • Other Routes of Administration

Therapy area (Revenue, USD Billion):

  • Cardiovascular Diseases (CVDs)
  • Pain
  • Diabetes
  • Cancer
  • Respiratory Diseases
  • Other Diseases

Prescription (Revenue, USD Billion):

  • Prescription Medicines
  • OTC Medicines

Age group (Revenue, USD Billion):

  • Children & Adolescents
  • Adults
  • Geriatric

Sales Channel (Revenue, USD Billion):

  • Retail
  • Non-retail

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 04 January 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up